Laboratory studies revealed hypercalcemia of unknown origin, accompanied by decreased parathyroid hormone (PTH) and elevated PTH-related peptide (PTHrP), raising suspicion for hypercalcemia of malignancy (Table 1). Here, PTHLH is linked to hypercalcemia disease.